obesity

The Indiana Youth Institute is highlighting the rise of obesity in central Indiana youth.

Lawmakers warn the arrangement Eli Lilly and Pfizer have with telehealth platforms may lead to conflicts of interest, subpar patient care, and increase in federal health care spending.

This change follows the recent FDA approval of the weight-loss drug for preventing heart attack and stroke in people with overweight or obesity.

New research shows the number of kids who qualify as obese in Central Indiana increased during the COVID-19 pandemic, with around 36% increase in obesity among young people ages 2-19.

The quick rise in popularity of the diabetes drugs used for weight loss over the last two years caught many employers flat footed. Now, employers are scrambling to find solutions to help improve worker health while simultaneously keeping a lid on rising health care spending.

There's already a huge demand for existing weight-loss drugs, so the new medication is highly anticipated. Obesity affects an estimated 650 million adults globally.

New research from Indiana University suggests that obesity in Black women increases their risk of recurrence of breast cancer or even dying — more so than in white women.

Indiana is one of 12 states with an obesity rate of at least 35 percent among adults, according to a new national report. COVID-19 and high obesity rates could aggravate health issues for an already at-risk population

Indianas rate has inched up from 31 percent in 2013 to just over 34 percent this year.

Indiana youth continue to have higher rates of obesity than the national average and according to a new national data analysis - some minorities in the state are at greater risk.